Invent Ventures, Inc. (OTCMKTS:IDEA) is a medical device and life-science technology company specializing in the design, development and manufacturing of respiratory care and drug delivery solutions. The company’s core product portfolio includes non-invasive and invasive ventilators, ultrasonic and mesh nebulizers, oxygen flow meters and aerosol drug-formulation platforms. By integrating advanced engineering with clinical insights, Invent Ventures aims to enhance patient outcomes in both hospital and home-care settings.
In addition to its proprietary respiratory therapy devices, Invent Ventures offers contract research and manufacturing services for original equipment manufacturers (OEMs) in the pharmaceutical and medical device sectors. These services encompass product design, prototyping, regulatory support and scalable production. The company’s flexible manufacturing capabilities allow it to serve a diverse clientele, from emerging biotech firms seeking to bring novel inhalation therapies to market to established medical-device companies requiring high-volume assembly.
Headquartered in Irvine, California, Invent Ventures maintains research and production facilities in North America and Asia Pacific, with distribution channels extending into Europe, Latin America and select markets in the Middle East. The company works closely with hospital systems, home-health providers and strategic partners to ensure its products meet regional regulatory standards and address local clinical needs. Its global footprint supports responsive customer service and supply-chain resilience.
Founded in 2007 by a group of biomedical engineers and respiratory therapists, Invent Ventures is led by a management team with extensive experience in medical-device innovation, regulatory affairs and global operations. The executive leadership emphasizes continuous investment in R&D, adherence to quality-management systems and collaboration with key opinion leaders. Through ongoing product enhancements and new technology development, the company seeks to address unmet needs in respiratory care and drug delivery worldwide.
AI Generated. May Contain Errors.
